Drug turns patients into gambling addicts

Sep 18, 2006

Scottish researchers have found that drugs used to treat Parkinson's disease appear to turn some patients into gambling addicts.

A survey of patients in western Scotland found that about 10 percent of those taking dopamine agents had become problem gamblers, The Scotsman reported. A research team from Southern General Hospital in Glasgow tracked 251 Parkinson's patients who were taking different drug combinations.

Many of the patients who became addicted were already regular bettors before they went on Parkinson's medication. But the increase was often dramatic, like the patient who went from spending 10 pounds a week gambling to 1,500 pounds a week.

Parkinson's patients appear to suffer from low levels of dopamine. Dopamine plays a role in addiction by helping the brain to recognize sources of pleasure.

Robert Brown, a Glasgow psychologist, said that what patients using dopamine are likely to turn to depends on what they have access to.

"There is a tradition of gambling across the whole of Scotland, with more gamblers per head of population than in England and Wales," Brown said. "But people on these drugs could equally turn to alcohol or other ways of finding arousal or escape."

Copyright 2006 by United Press International

Explore further: Drug prices to treat multiple sclerosis soar, point to larger problem

Related Stories

Parkinson's patients' 'risky behavior' explained

Jun 23, 2010

Scientists at UCL (University College London) have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.

Recommended for you

Mylan rebuffs Teva again; calls bid low, insincere

2 hours ago

Generic drug company Mylan rejected for the second time Monday a $40.1 billion takeover offer from Israeli pharmaceutical power Teva, just days after Mylan's own bid for rival Perrigo was rebuffed.

Rising antibiotic shortages raise concerns about patient care

Apr 23, 2015

Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Di ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.